1. Academic Validation
  2. Stoichiometric and irreversible cysteine-selective protein modification using carbonylacrylic reagents

Stoichiometric and irreversible cysteine-selective protein modification using carbonylacrylic reagents

  • Nat Commun. 2016 Oct 26;7:13128. doi: 10.1038/ncomms13128.
Barbara Bernardim 1 2 Pedro M S D Cal 1 3 Maria J Matos 1 Bruno L Oliveira 1 Nuria Martínez-Sáez 1 Inês S Albuquerque 3 Elizabeth Perkins 4 Francisco Corzana 1 5 Antonio C B Burtoloso 2 Gonzalo Jiménez-Osés 5 6 Gonçalo J L Bernardes 1 3
Affiliations

Affiliations

  • 1 Department of Chemistry, University of Cambridge, Lensfield Road, CB2 1EW Cambridge UK.
  • 2 Instituto de Química de São Carlos, Universidade de São Paulo, São Carlos, São Paulo CEP 13560-970, Brazil.
  • 3 Instituto de Medicina Molecular, Faculdade de Medicina, Universidade de Lisboa, Avenida Professor Egas Moniz, 1649-028 Lisboa, Portugal.
  • 4 Albumedix Ltd, Castle Court, 59 Castle Boulevard, Nottingham NG7 1FD, UK.
  • 5 Departamento de Química, Universidad de La Rioja, Centro de Investigacioón en Síntesis Química, 26006 Logroño, Spain.
  • 6 Institute of Biocomputation and Physics of Complex Systems (BIFI), University of Zaragoza, BIFI-IQFR (CSIC), 50018 Zaragoza, Spain.
Abstract

Maleimides remain the reagents of choice for the preparation of therapeutic and imaging protein conjugates despite the known instability of the resulting products that undergo thiol-exchange reactions in vivo. Here we present the rational design of carbonylacrylic reagents for chemoselective cysteine bioconjugation. These reagents undergo rapid thiol Michael-addition under biocompatible conditions in stoichiometric amounts. When using carbonylacrylic reagents equipped with PEG or fluorophore moieties, this method enables access to protein and antibody conjugates precisely modified at pre-determined sites. Importantly, the conjugates formed are resistant to degradation in plasma and are biologically functional, as demonstrated by the selective imaging and detection of apoptotic and HER2+ cells, respectively. The straightforward preparation, stoichiometric use and exquisite cysteine selectivity of the carbonylacrylic reagents combined with the stability of the products and the availability of biologically relevant cysteine-tagged proteins make this method suitable for the routine preparation of chemically defined conjugates for in vivo applications.

Figures
Products